View Post

Gottlieb at BIO: FDA developing processes around right-to-try law

In In The News by Barbara Jacoby

By: ALARIC DEARMENT From: Perhaps it was inevitable that with Food and Drug Administration Commissioner Scott Gottlieb speaking before an auditorium full of biotechnology executives, a particularly contentious topic would come up: the new right-to-try law. Gottlieb was at the BIO annual meeting in Boston Thursday for a fireside chat with the organization’s president, Jim Greenwood. During the question-and-answer session, …